We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+1.97%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$32.2B
AUM Growth
+$1.15B
(+3.7%)
Cap. Flow
+$886M
Cap. Flow
% of AUM
2.75%
Top 10 Holdings %
Top 10 Hldgs %
14.34%
Holding
3,060
New
26
Increased
2,469
Reduced
354
Closed
63
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$23.3M |
| 2 |
ExxonMobil
XOM
|
+$22.8M |
| 3 |
Apple
AAPL
|
+$21.5M |
| 4 |
Wells Fargo
WFC
|
+$19.8M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$17.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$43M |
| 2 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$42.1M |
| 3 |
GMCR
KEURIG GREEN MTN INC
GMCR
|
+$17.2M |
| 4 |
Chubb
CB
|
+$13.7M |
| 5 |
TW
TOWERS WATSON & CO COM STK CL A (DE)
TW
|
+$13.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.4% |
| 2 | Financials | 14.39% |
| 3 | Healthcare | 13.67% |
| 4 | Industrials | 10.84% |
| 5 | Consumer Discretionary | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Acacia Research
ACTG
$439M
| $302K | ﹤0.01% |
79,696
+7,185
| +10% | +$26.4K |
|
|
SREV
2527
DELISTED
ServiceSource International, Inc.
SREV
| $302K | ﹤0.01% |
70,800
+4,285
| +6% | +$17.3K |
|
|
BEAT
2528
DELISTED
BioTelemetry, Inc.
BEAT
| $302K | ﹤0.01% |
25,892
+460
| +2% | +$5.14K |
|
|
SNBC
2529
DELISTED
Sun Bancorp Inc
SNBC
| $302K | ﹤0.01% |
14,597
+1,345
| +10% | +$27.8K |
|
2530
Foster
FSTR
$438M
| $299K | ﹤0.01% |
16,485
+1,450
| +10% | +$19.3K |
|
2531
The Bancorp
TBBK
$2.99B
| $299K | ﹤0.01% |
52,357
+4,730
| +10% | +$23.6K |
|
|
LJPC
2532
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $299K | ﹤0.01% |
14,302
+1,040
| +8% | +$18.5K |
|
2533
Agilysys
AGYS
$3.12B
| $297K | ﹤0.01% |
29,084
+2,645
| +10% | +$26.8K |
|
|
STRP
2534
DELISTED
Straight Path Communications Inc.
STRP
| $296K | ﹤0.01% |
+9,535
| New | +$238K |
|
|
CSCD
2535
DELISTED
CASCADE MICROTECH, INC.
CSCD
| $295K | ﹤0.01% |
14,285
+335
| +2% | +$6.22K |
|
|
CTO
2536
CTO Realty Growth
CTO
$817M
| $294K | ﹤0.01% |
23,438
+1,621
| +7% | +$20.8K |
|
2537
TG Therapeutics
TGTX
$7.64B
| $293K | ﹤0.01% |
34,440
+40
| +0.1% | +$350 |
|
|
PGEM
2538
DELISTED
Ply Gem Holdings, Inc.
PGEM
| $293K | ﹤0.01% |
20,837
+75
| +0.4% | +$803 |
|
|
AAMI
2539
Acadian Asset Management
AAMI
$3.26B
| $292K | ﹤0.01% |
21,848
| – | – |
|
|
GCAP
2540
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $292K | ﹤0.01% |
44,527
+4,255
| +11% | +$29.5K |
|
|
XENT
2541
DELISTED
Intersect ENT, Inc
XENT
| $291K | ﹤0.01% |
15,293
+65
| +0.4% | +$1.18K |
|
|
RVNC
2542
DELISTED
Revance Therapeutics, Inc.
RVNC
| $290K | ﹤0.01% |
16,610
+590
| +4% | +$12K |
|
2543
Hovnanian Enterprises
HOV
$808M
| $289K | ﹤0.01% |
7,414
+671
| +10% | +$25.4K |
|
2544
Manulife Financial
MFC
$73.9B
| $289K | ﹤0.01% |
20,470
| – | – |
|
2545
Mesa Laboratories
MLAB
$574M
| $289K | ﹤0.01% |
2,998
| – | – |
|
2546
Ezcorp Inc
EZPW
$1.83B
| $288K | ﹤0.01% |
96,847
+8,290
| +9% | +$25.9K |
|
|
SCMP
2547
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $288K | ﹤0.01% |
26,350
+170
| +0.6% | +$2.15K |
|
|
CLMS
2548
DELISTED
Calamos Asset Management, Inc.
CLMS
| $288K | ﹤0.01% |
33,902
+3,025
| +10% | +$26.9K |
|
|
PWOD
2549
DELISTED
Penns Woods Bancorp
PWOD
| $287K | ﹤0.01% |
11,184
+982
| +10% | +$25.6K |
|
2550
STAAR Surgical
STAA
$1.14B
| $287K | ﹤0.01% |
38,891
+360
| +0.9% | +$2.44K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2016 Portfolio in Review
As of Q1 2016, RhumbLine Advisers held 3,060 positions worth $32.2B, up 3.7% from $31.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Trading was light in Q1 2016: portfolio turnover was 2.9%. RhumbLine Advisers opened 26 new positions and exited 63, leaving the 3,060-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2016 buy was Willis Towers Watson: 89,353 shares worth $10.6M.
- RhumbLine Advisers added most to Broadcom in Q1 2016, an estimated $23.3M increase.
- RhumbLine Advisers's biggest Q1 2016 reduction was Chubb, cutting an estimated $13.7M.
- RhumbLine Advisers fully exited BROADCOM CORP CL-A in Q1 2016, selling an estimated $43M.
- RhumbLine Advisers's ten largest holdings make up 14% of its $32.2B portfolio in Q1 2016.
- RhumbLine Advisers opened 26 new positions and closed 63 in Q1 2016.
- RhumbLine Advisers's portfolio value rose 3.7% quarter-over-quarter to $32.2B.
Based on RhumbLine Advisers's 13F filing for Q1 2016, filed 2 May 2016.